Staying a step ahead may not always be easy for companies like Verita Neuro, but it is certainly a very rewarding position to hold, especially if the effectiveness of most of your treatments is confirmed by a university as prestigious as the University of Texas – Southwestern Medical Center.
Therefore, it does not come as a surprise to read in a recent article published by Science Daily, that the UT Southwestern Medial Center has managed to successfully stimulate the regeneration of mature nerve cells in the spinal cord. For the time being, this research was only done on adult mammals and yet the scientists behind this study have faith that, in the near future, patients suffering from Spinal Cord Injuries will be able to greatly benefit from this new medical advancement.
These findings were lead by the researchers Dr. Lei Lei Want and Dr. Zhang, a W.W. Caruth, Jr. Scholar in Biomedical Research and member of the Hamon Center for Regenerative Science and Medicine. Both doctors feel confident of the possibility of regenerating neurons that may aid spinal cord injury patients, even though conventional medicine confirms that the ability of doing so with standard methodologies is somewhat limited.
As Dr. Zhang pointed out: “Our ability to successfully produce a large population of long-lived and diverse subtypes of new neurons in the adult spinal cord provides a cellular basis for regeneration-based therapy for spinal cord injuries. If borne out by future studies, this strategy would pave the way for using a patient’s own glial cells, thereby avoiding transplants and the need for immunosuppressive therapy.“
Verita Neuro offers services that live up to Dr. Zhang’s prodigious research. The use of mesenchymal stem cells has greatly benefited countless patients throughout the years and will continue to do so in the following years. We feel confident that studies like his, which are currently being carried at Western universities, will be a key factor in spreading awareness amongst all those who are in need of a quality medical treatment that delivers results.
It might be ambitious to state the following, but with the countless scientific advances that are being developed by different institutions and private organisations worldwide, there will eventually be a way of regenerating the damage that many Spinal Cord Injury patients suffer from, in ways that are currently unimaginable. We can only look at the future with bright optimism and realise that if many patients are today greatly improving their quality of life with regenerative treatments, these benefits will pale in comparison with what the not so distant future has in store for them.
Needless to say, Verita Neuro will be on the cutting edge of medical innovation now and in the years to come and we will proudly help all those in need of high-quality treatments.
H/T Science Daily